Navigation Links
MedCath Corporation Reports Second Quarter Earnings and Provides Update to Internal Assessment
Date:5/21/2009

FINANCIAL MEASURES TO NON-GAAP FINANCIAL MEASURES (Unaudited) The following table reconciles Adjusted EBITDA with MedCath's income from continuing operations as derived directly from MedCath's consolidated financial statements for the three and six months ended March 31, 2009 and 2008. Three Months Six Months Ended March 31, Ended March 31, 2009 2008 2009 2008 (in thousands) (in thousands) Income from continuing operations $5,418 $5,486 $3,802 $7,776 Add: Income tax expense 3,372 3,099 2,463 5,448 Minority interest share of earnings of consolidated subsidiaries 4,639 4,642 7,415 8,779 Equity in net earnings of unconsolidated affiliates (2,714) (2,181) (4,779) (4,206) Interest and other income, net (73) (485) (173) (1,646) (Gain) loss on early extinguishment of debt (259) - 6,702 - Interest expense 1,338 3,864 4,194 7,796 Loss on disposal of property, equipment and other assets 91 138 164 166 Amortization 210 135 359 262 Depreciation 7,565 7,689 15,400 15,030 Pre-opening expenses 380 245 587 493 Share-based compensation expense 839 213 1,837 3,922 Adjusted EBITDA $20,806 $22,845 $37,971 $43,820


'/>"/>
SOURCE MedCath Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. MedCath Corporation Reports Fourth Quarter Earnings and Outlook for Fiscal 2008
2. MedCath Corporation to Present at the BMO Capital Markets 2007 Focus on Healthcare Conference
3. MedCath Corporation to Present at the 26th Annual JPMorgan Healthcare Conference
4. MedCath Corporation to Hold Conference Call on First Quarter Results
5. MedCath Corporation Reports First Quarter Earnings
6. MedCath Plans 60-bed Expansion at TexSAn Heart Hospital
7. MedCath Announces Venture With Two New Jersey Hospitals
8. MedCath Corporation to Present at the Raymond James 29th Annual Institutional Investors Conference
9. MedCath Corporation to Present at the Citi 2008 Small and Mid-Cap Conference
10. MedCath Enters Definitive Agreement to Sell Dayton Heart Hospital to Good Samaritan Hospital-Dayton
11. MedCath Announces Acquisition of Ownership in Arizona Cath Lab
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... The sodium theory has ... B. Katz in the early 1950s, after their experiments ... sodium and potassium ions in nerve functions . ... techniques have known amazing developments. In The Sodium Theory ... an account of the latest developments in the field ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Voyance, ... and perception management tools, and ASCA, the industry’s ... the new ASCA Benchmarking Program. Voyance ... technology and national benchmarking experience to support ASCA’s ... comprehensive, state-of-the-art benchmarking tool. , “Voyance is both ...
(Date:5/23/2013)... Park, FL (PRWEB) May 23, 2013 ... Day Belly Blast Diet to determine what makes this ... , The published review highlights three main components of ... rate; achieving a positive mindset and the personal motivation ... calorie intake every 7 days to keep the metabolism ...
(Date:5/23/2013)... eat at fast-food restaurants are consuming significantly more calories ... offenders, a new study found. "Teens underestimate the ... as 34 percent, parents of school-age children by as ... as 20 percent," study lead researcher, Dr. Jason Block, ... Johnson Foundation, which helped fund the study. ...
(Date:5/23/2013)... Susquehanna Health is now ... babysitting training course for adolescents age 11 and up. ... pediatrician Dr. Patricia Keener after a colleague’s toddler choked ... sitter who didn’t know how to provide first aid. ... a medical basis that aims to reduce the number ...
Breaking Medicine News(10 mins):Health News:Yves Pichon’s New Book Presents Latest Neurophysiological Discoveries 2Health News:Yves Pichon’s New Book Presents Latest Neurophysiological Discoveries 3Health News:Voyance and ASCA Announce Strategic Partnership to Better the ASC Industry 2Health News:Voyance and ASCA Announce Strategic Partnership to Better the ASC Industry 3Health News:Onlinefitnessreview.com Publishes 7 Day Belly Blast Diet Review 2Health News:How Many Calories in Your Fast-Food Meal? Guess Again 2Health News:Susquehanna Health Offers Safe Sitter Course for Tweens and Teens 2Health News:Susquehanna Health Offers Safe Sitter Course for Tweens and Teens 3
... in Central Mexico who used a vented stove instead of ... par with a pack-a-day smoker kicking the habit, according to ... first year of data in an ongoing project examining the ... open fires, was reported in the October 1 issue of ...
... NEW YORK, Sept. 22 Preet Bharara, the U.S. Attorney ... Dowd, formerly the senior manager of human resources of Hitachi America ... 57 months in prison for defrauding the Hitachi America Group Health ... sentence was imposed by U.S. District Judge Colleen McMahon. Dowd pleaded ...
... ... bioidentical hormone replacement therapy and nutritional supplements in battle against the deadly disease ... Jacksonville, Fla. (Vocus) ... than five million people in the United States and 35 million people worldwide are ...
... , NEW YORK, Sept. 22 Assurant, Inc. ("Assurant") (NYSE: ... products and services, will release 2009 third quarter financial results on Wednesday, ... available on Assurant,s Web site at www.assurant.com . , ... conference call at 9:00 a.m. ET on Thursday, Oct. 29, 2009 with ...
... , , , , ... provide affordable health insurance for all, , , ... public or private , , Sixty-three percent favor ... A nationwide survey commissioned by the United States Conference of Catholic Bishops ...
... , , SCHAUMBURG, Ill., Sept. 22 ... Peter Beilenson, MD, MPH, announced they are introducing a regulation to ... of indoor tanning devices for all residents under the age of ... its kind in the nation. , , "The ...
Cached Medicine News:Health News:New stove dramatically improves lung health in Mexican women 2Health News:New stove dramatically improves lung health in Mexican women 3Health News:Former Corporate Benefits Manager Sentenced to 57 Months in Prison for Defrauding Health Care Plan of More Than $6 Million Dollars 2Health News:Report Finds Alzheimer's Killing More People Than Breast And Prostate Cancer Combined 2Health News:Report Finds Alzheimer's Killing More People Than Breast And Prostate Cancer Combined 3Health News:Report Finds Alzheimer's Killing More People Than Breast And Prostate Cancer Combined 4Health News:Report Finds Alzheimer's Killing More People Than Breast And Prostate Cancer Combined 5Health News:Assurant to Announce 2009 Third Quarter Results Oct. 28, 2009 and Host Webcast Conference Call Oct. 29 2Health News:New Survey: Most Americans Want Health Care Reform, Oppose Abortion Coverage, Support Conscience Protection Laws 2Health News:American Academy of Dermatology Association Commends Howard County for Proposing the Most Restrictive Indoor Tanning Regulation in the Country 2
(Date:5/23/2013)... , May 23, 2013  Intercept Pharmaceuticals, Inc. ... biopharmaceutical company focused on the development and commercialization of ... such as primary biliary cirrhosis, today announced that ... Executive Officer, will present at the Deutsche Bank Securities ... on Wednesday, May 29, 2013 at 4:10 ...
(Date:5/23/2013)...  Omeros Corporation (NASDAQ: OMER ) ... (IND) to evaluate OMS824 in Huntington,s disease has ... Administration (FDA). OMS824 selectively inhibits phosphodiesterase 10 (PDE10), ... linked to a wide range of diseases that ... has shown promising results in animal models directly ...
(Date:5/23/2013)... 23, 2013  MedVantx, Inc., the company that has ... announced today the Company has completed a major expansion ... pharmaceutical products and the upgrade of its systems to ... in its specialty home delivery pharmacy in ... pharmaceutical manufacturers, physicians, health systems and payors novel distribution ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 2MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 3
... ... Study, Pharmacokinetic Study Demonstrates Lack of Systemic Exposure of XIAFLEX, ... Conference call scheduled for today, June 3, at 8:45 a.m. Eastern Time, ... positive top-line,efficacy and safety results from the CORD I and CORD II phase ...
... 2 Alliance,Pharmaceutical Corp. (OTC Bulletin Board: ALLP) announced ... the two proposals put to the,shareholders at its Annual ... first proposal related to the re-election of each of ... additional term of one year or,until their successors are ...
Cached Medicine Technology:Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 2Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 3Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 4Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 5Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 6Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 7Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 8Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 9Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 10Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 11Alliance Pharmaceutical Corp. Announces Approval of Proposed Actions at Annual Shareholders Meeting 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: